K. Moribe et al., Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives, INT J PHARM, 188(2), 1999, pp. 193-202
In this study, we characterized the encapsulation of amphipathic nystatin i
nto liposomes with or without cholesterol (CH) and a polyethylene glycol de
rivative, distearoyl-N-(monomethoxy poly(ethylene glycol)succinyl)phosphati
dylethanolamine (DSPE-PEG). The highest encapsulation efficacy of nystatin
into liposomes (151 mu g nystatin/mg lipid) was obtained with a cholesterol
-free lipid composition containing 6 mol% of DSPE-PEG. The encapsulation ef
ficacy was decreased by the incorporation of CH and improved by the incorpo
ration of DSPE-PEG. In liposomes composed of dipalmitoylphosphatidylcholine
(DPPC)/CH (2:1, mol/mol), the highest encapsulation efficacy of nystatin l
iposomes (84 mu g/mg lipid) was achieved by the addition of DSPE-PEG and hy
dration with 9% sucrose solution, as compared with 13 mu g/mg lipid without
DSPE-PEG. The encapsulated amount increased with increasing amount of DSPE
-PEG used and plateaued at 6 mol% of DSPE-PEG. The optimum molecular weight
of PEG in DSPE-PEG was 2000 and a larger molecular weight resulted in lowe
r encapsulation. The incorporation of CH affected the self-association of n
ystatin with lipid membranes, which was detected by fluorescence measuremen
t. The molecular interaction between an amino group in nystatin and a phosp
hate group in DSPE-PEG plays an important role in efficient encapsulation o
f nystatin. Finally, the encapsulation characteristics of nystatin were com
pared with those of amphotericin B (AmB). Nystatin more readily associated
with CII-free lipid membranes, but, AmB more readily interacted with DSPE-P
EG. The results indicated that the differences in the molecular association
of AmB or nystatin with lipids or DSPE-PEG are reflected in the encapsulat
ion characteristics in liposomes. (C) 1999 Elsevier Science B.V. All rights
reserved.